Key result
Dobutamine echocardiography had 69% sensitivity and 100% specificity for predicting functional recovery in akinetic/dyskinetic segments, but sensitivity was lower in wall-thinned segments.
Why the study?
Does dobutamine echocardiography accurately predict post-revascularization functional recovery in patients with chronic coronary artery disease?
Observational (n=53)
Does dobutamine echocardiography accurately predict post-revascularization functional recovery in patients with chronic coronary artery disease?
Dobutamine echocardiography has reduced sensitivity for predicting functional recovery after revascularization in akinetic/dyskinetic myocardial segments with thinned end-diastolic wall thickness.
Answers are grounded in this paper and cite their sources.
Dobutamine echo sensitivity drops in thinned segments warranting multimodal assessment; leaves open refinement of viability criteria in chronic CAD.
AIMS: This study investigated the functional outcome of wall-thinned, akinetic myocardium after revascularization and evaluated the accuracy of dobutamine echocardiography in predicting post-revascularization functional recovery with the assessment of end-diastolic wall thickness in chronic ischaemic patients. METHODS AND RESULTS: Fifty-three patients underwent dobutamine echocardiography before coronary revascularization. End-diastolic wall thickness was also evaluated before and after revascularization. The sensitivity and specificity of dobutamine echocardiography to predict postrevascularization functional recovery were 69% and 100% in 58 akinetic/dyskinetic segments, and 86% and 57% in 96 hypokinetic segments. Of 19 akinetic/dyskinetic segments with a preserved end-diastolic wall thickness, 17 (89%) showed functional recovery after revascularization, and dobutamine detected 14 (83%) of these 17 segments. Of 39 akinetic/dyskinetic segments with a thinned end-diastolic wall thickness, 15 (38%) achieved functional recovery, whereas dobutamine echocardiography detected recovery in only eight (53%). Further, of these 15 viable, Wall-thinned segments, 12 (80%) showed an increased end-diastolic wall thickness after revascularization (mean +/- SD were from 5.6 +/- 0.7 mm at baseline to 7.4 +/- 1.3 mm and 9.7 +/- 1.4 mm after 1 week and after 3 months, respectively), and only 5 (42%) of these responded to dobutamine. CONCLUSION: Dobutamine echocardiography showed a lessened sensitivity to predict post-revascularization functional recovery in akinetic/dyskinetic segments with a thinned end-diastolic wall thickness that subsequently increased in size.
No takes yet. Share an insight, caveat, or question.
Furukawa et al. (1997) conducted an observational in chronic coronary artery disease (n=53). Dobutamine echocardiography was evaluated on post-revascularization functional recovery. Dobutamine echocardiography had 69% sensitivity and 100% specificity for predicting functional recovery in akinetic/dyskinetic segments, but sensitivity was lower in wall-thinned segments.
Synapse has enriched 10 related papers. Consider them for comparative context: